Euro Q4 Earnings Preview: GSK, Sanofi, Bayer And Reckitt
Major Europe-based consumer health players GSK, Sanofi, Bayer and Reckitt feature in this earnings preview, which highlights what to look out for as these four firms report their Q4 and annual results over the coming weeks.
You may also be interested in...
Procter & Gamble CEO Jon Moeller and and feminine products chief Jennifer Davis outline firm's strategies and focus areas in sustainability and superiority in 2022. While more than half consumers are interested in natural or more sustainable products, few will settle for lesser product performance, Davis said. But they appear willing to pay a premium for products made with sustainable materials.
The French major has committed up to £5m for non-profit Protas, which aims to facilitate large clinical studies at a fraction of the usual price and form more pharmaceutical collaborations down the line.
Unilever's decision not to increase its £50bn bid for GSK Consumer Healthcare has been widely welcomed by analysts. But they warn that the aborted move for GSK has damaged investor confidence in Unilever’s management.